炎琥宁治疗急性病毒性上呼吸道感染的临床研究  

Clinical values of Yanhuningin treatment for acute viral infections in upper respiratory tract

作　　者：叶雪梅[1] 谢红[1] 叶玉兰[2] 

机构地区：[1]四川眉山眉山市人民医院重症科,610020 [2]成都市第一人民医院神经内科

出　　处：《国际病毒学杂志》2015年第5期307-310,共4页International Journal of Virology

摘　　要：目的 探讨炎琥宁治疗急性病毒性上呼吸道感染的临床效果及对患者血清淀粉样蛋白A（SAA）的影响.方法 将急性病毒性上呼吸道感染的患者88例随机分为对照组和观察组,每组各44例.对照组采用常规对症治疗,观察组在对照组治疗基础上加用炎琥宁共同治疗.结果 观察组患者总有效率为97.73％,对照组患者总有效率为81.82％,两组差异具有统计学意义（P＜0.05）.治疗后,两组患者SAA水平与治疗前相比呈下降趋势,且观察组患者SAA水平下降幅度高于对照组患者SAA水平,差异具有统计学意义（P＜0.01）.治疗后,观察组患者临床症状改善情况优于对照组临床症状改善情况,差异有统计学意义（P＜0.05）.结论 采用炎琥宁治疗急性病毒性上呼吸道感染能有效的提高其治疗效果,减轻患者炎症反应,改善患者生活质量.Objective To analyze the clinical values of Yanhuningin treatment for acute viral respiratory infection and its impacts on serum amylojd A.Methods Eighty eight patients with acute viral respiratory infection were randomly divided into control group and observation group, 44 cases in each group.The control group was treated with conventional symptomatic therapy and the observation group was treated with Yanhuning on the basis of the conventional symptomatic therapy.Results The total efficiency rate of the observation group was 97.73% and 81.82% in the control group.There was statistical difference between the two groups （P 〈0.05）.After treatment, SAA levels in both groups declined compared with before treatment.SAA levels of the observation group patient declined more than that of the control group.The difference of two group was statistically significant （P 〈 0.01）.After treatment, improvement of clinical symptoms for the observation group patients was better than that of the control group and the difference was statistically significant （P 〈 0.05）.Conclusions The clinical effect of Yanhuning is good in the treatment of acute viral respiratory infections with effectively improved therapeutic effect.It can reduce inflammation and improve better quality of life in patients.

关 键 词：炎琥宁 急性病毒性上呼吸道感染 血清淀粉样蛋白A 

分 类 号：R56[医药卫生—呼吸系统]